VLA 0.00% $1.75 viralytics limited

Gilead buys Kite Pharma for $11.9 BN, page-19

  1. 12,221 Posts.
    lightbulb Created with Sketch. 1087
    Hi,
    The company has already told us the trials are progressing well.
    Why not , no adverse effect 67% Orr for people that have already failed Checkpoint .
    What's not to like if you in that position.
    I would imagine the Keynote will be last of the results released.
    Aloha
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.